Analysen von Emily Field
02.11.22 | Merck Overweight | Barclays Capital | |
01.11.22 | AstraZeneca Overweight | Barclays Capital | |
27.10.22 | AstraZeneca Overweight | Barclays Capital | |
19.10.22 | Roche Overweight | Barclays Capital | |
18.10.22 | Roche Overweight | Barclays Capital | |
14.10.22 | Novo Nordisk Overweight | Barclays Capital | |
10.10.22 | Merck Overweight | Barclays Capital | |
07.10.22 | Merck Overweight | Barclays Capital | |
Werbung
|
|||
03.10.22 | Novo Nordisk Overweight | Barclays Capital | |
29.09.22 | Roche Overweight | Barclays Capital | |
31.08.22 | Bayer Overweight | Barclays Capital | |
29.08.22 | Bayer Overweight | Barclays Capital | |
16.08.22 | Merck Overweight | Barclays Capital | |
15.08.22 | Novo Nordisk Overweight | Barclays Capital | |
15.08.22 | Bayer Overweight | Barclays Capital | |
04.08.22 | Novo Nordisk Overweight | Barclays Capital | |
04.08.22 | AstraZeneca Overweight | Barclays Capital | |
04.08.22 | Merck Overweight | Barclays Capital | |
18.07.22 | Merck Overweight | Barclays Capital | |
18.07.22 | Novo Nordisk Overweight | Barclays Capital | |
18.07.22 | AstraZeneca Overweight | Barclays Capital | |
18.07.22 | Roche Overweight | Barclays Capital | |
18.07.22 | Bayer Overweight | Barclays Capital | |
15.07.22 | Bayer Overweight | Barclays Capital | |
22.06.22 | Bayer Overweight | Barclays Capital | |
21.06.22 | Bayer Overweight | Barclays Capital | |
13.06.22 | Novo Nordisk Overweight | Barclays Capital | |
10.06.22 | Bayer Overweight | Barclays Capital | |
12.05.22 | Merck Overweight | Barclays Capital | |
12.05.22 | Novo Nordisk Overweight | Barclays Capital | |
11.05.22 | Roche Overweight | Barclays Capital | |
11.05.22 | Bayer Overweight | Barclays Capital | |
10.05.22 | Bayer Overweight | Barclays Capital | |
04.05.22 | Merck Overweight | Barclays Capital | |
26.04.22 | Roche Overweight | Barclays Capital | |
04.04.22 | Bayer Overweight | Barclays Capital | |
30.03.22 | Roche Overweight | Barclays Capital | |
04.03.22 | Merck Overweight | Barclays Capital | |
15.02.22 | Novo Nordisk Overweight | Barclays Capital | |
15.02.22 | AstraZeneca Overweight | Barclays Capital | |
07.02.22 | Roche Overweight | Barclays Capital | |
04.02.22 | Roche Overweight | Barclays Capital | |
31.01.22 | Roche Overweight | Barclays Capital | |
31.01.22 | AstraZeneca Overweight | Barclays Capital | |
31.01.22 | Novo Nordisk Overweight | Barclays Capital | |
21.12.21 | Novo Nordisk Overweight | Barclays Capital | |
22.11.21 | Novo Nordisk Overweight | Barclays Capital | |
10.11.21 | AstraZeneca Overweight | Barclays Capital | |
04.11.21 | Novo Nordisk Overweight | Barclays Capital | |
20.10.21 | Roche Overweight | Barclays Capital |